Exposure to hydroxyurea during pregnancy in sickle-β Thalassemia: A report of 2 cases

Journal of Clinical Pharmacology

Volumn 50, Issue 2, 2010, Pages 231-234

  Italia, Khushnooma Y ^a   Jijina, Farah F ^a   Chandrakala, S ^a   Nadkarni, Anita H ^a   Sawant, Pratibha ^a   Ghosh, Kanjaksha ^a   Colah, Roshan B ^a  

^a KEM HOSPITAL   (India)

Author keywords

Hydroxyurea; Pregnancy; Sickle thalassemia

Indexed keywords

BICARBONATE; FOLIC ACID; HEMOGLOBIN; HYDROXYUREA; TRAMADOL;

ADULT; ARTICLE; BACKACHE; BLOOD TRANSFUSION; CASE REPORT; DRUG EXPOSURE; DRUG WITHDRAWAL; FEMALE; FETUS; FETUS DISTRESS; FETUS ECHOGRAPHY; FETUS MONITORING; FLUID INTAKE; FOLLOW UP; HAPLOTYPE; HUMAN; PREGNANCY; PRENATAL CARE; SICKLE CELL BETA THALASSEMIA; THORAX PAIN;

ADULT; ANEMIA, SICKLE CELL; ANTISICKLING AGENTS; BETA-THALASSEMIA; FEMALE; FETUS; HUMANS; HYDROXYUREA; INFANT; INFANT, NEWBORN; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; TREATMENT OUTCOME;

EID: 75749125782     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270009343933     Document Type: Article

References (17)

1. Carlson J., Nash G., Gabutti V., Al- Yaman F., Wahlgren M. Natural protection against severe Plasmodium falciparum malaria due to impaired rosette formation. Blood. 1994 ; 84: 3909-3914.
2. Bhatia HM, Rao VR Genetic Atlas of the Indian Tribes. Bombay, India: Institute of Immunohaematology ; 1987.
3. Mohanty D., Mukherjee M. Sickle cell disease in India. Curr Opin Hematol. 2002 ; 9: 117-122.
4. Mukherjee MB, Lu CY, Ducrocq R., et al. Effect of ±-thalassemia on sickle-cell anemia linked to the Arab-Indian haplotype in India. Am J Hematol. 1997 ; 55: 104-109.
5. Charache S., Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med. 1995 ; 332: 1317-1322.
6. Italia K., Jain D., Gattani S., et al. Hydroxyurea in sickle cell disease: a study of clinico-pharmacological efficacy in the Indian haplotype. Blood Cells Mol Dis. 2009 ; 42: 25-31.
7. De Simone J., Heller P., Hall L., Zwiers D. 5-Azacytidine stimulates fetal hemoglobin synthesis in anemic baboons. Proc Natl Acad Sci USA. 1982 ; 79: 4428.
8. Gambari R. The human erythroleukemia K562 cell culture system for identification of inducers of fetal hemoglobin. Minerva Biotechnologia. 2003 ; 15: 123-128.
9. Bradai M., Abad MT, Pissard S., Lamraoui F., Skopinski L., Montalembert M. Hydroxyurea can eliminate transfusion requirements in children with severe β-thalassemia. Blood. 2003 ; 102: 1529-1530.
10. Schardein JL, ed. Chemically Induced Birth Defects. 2 nd ed. New York: Marcel Dekker ; 1993.
11. Chaube S., Murphy ML The effects of hydroxyurea and related compounds on the rat fetus. Cancer Res. 1966 ; 26: 1448-1457.
12. Ferm VH Severe developmental malformations: malformations induced by urethane and hydroxyurea in the hamster. Arch Pathol. 1966 ; 81: 174-177.
13. Khera KS A teratogenicity study on hydroxyurea and diphenylhydantoin in cats. Teratology. 1979 ; 20: 447-452.
14. Wilson JG, Scott WJ, Ritter EJ, Fadkin R. Comparative distribution and embryotoxicity of hydroxyurea in pregnant rats and rhesus monkeys. Teratology. 1975 ; 11: 169-178.
15. Diav-Citrin O., Hunnisett L., Sher GD, Koren G. Hydroxyurea use during pregnancy: a case report in sickle cell disease and review of the literature. Am J Hematol. 1999 ; 60: 148-150.
16. Byrd DC, Pitts SR, Alexander CK Hydroxyurea in two pregnant women with sickle cell anemia. Pharmacotherapy. 1999 ; 19: 1459-1462.
17. Robinet CT, Maingueneau C., Robert E., et al. Exposure to hydroxyurea during pregnancy: a case series. Leukemia. 2001 ; 15: 1309-1311.